2030년까지 유럽 형질감염 시약 및 장비 시장 예측 - 지역 분석 - 제품별(시약 및 기기), 방법(바이러스 방법, 비바이러스 방법 및 하이브리드 방법), 응용(생의학 연구, 단백질 생산 및 치료 전달) 및 최종 사용자(학술·연구기관, 제약·생명공학 기업)
기업별 전략적 이니셔티브가 유럽 형질감염 시약 및 장비 시장을 주도합니다
형질감염은 개발 과정의 전체 과정에서 복잡한 단계입니다. 아데노바이러스, 아데노 관련 바이러스 및 렌티바이러스를 포함하는 바이러스 벡터입니다. 제조 공정의 규모가 확대됨에 따라 일시적인 형질감염도 증가해야 합니다. 공정 장비 공급업체, 의약품 개발자 및 원자재 공급업체는 바이러스 벡터 제조 공정의 신속한 개발 및 확장을 위한 비용 효율적이고 실용적이며 플랫폼화 가능한 솔루션을 개발하기 위한 협력에 중점을 두고 있습니다. 소규모에서는 계획된 재료 용량과 이동 및 혼합 시간을 통해 여러 플라스미드로 세포를 형질감염시키는 것이 가능해집니다. 대부분의 회사는 실험실 수준에서만 형질감염 경험을 갖고 있기 때문에 규모를 확대하려면 형질감염 단계를 산업화하는 경험이 필요합니다. 그러나 프로세스를 더 큰 수준으로 확장하는 데 필요한 세포 배양 배지 및 형질감염 시약의 양은 비실용적일 수 있으므로 최적화의 필요성이 강조됩니다. 그럼에도 불구하고 최근에는 바이러스 벡터에 대한 수요가 급증하면서 생산 규모를 확대하는 것이 일반화되었습니다. 대규모 형질감염 공정과 관련된 수많은 문제로 인해 생산량을 늘리는 가장 좋은 방법은 공정을 확장하는 것보다 공정을 줄이는 것입니다. 이러한 하향식 접근 방식을 통해 형질감염 복합 용액의 양과 같이 산업 수준에서 프로세스에 영향을 미치는 조건을 명확하게 식별할 수 있습니다. 또한 이 접근 방식은 프로세스 최적화 및 의사 결정을 촉진합니다. 소규모 형질감염 공정을 강화하기 위한 이러한 접근법의 개발은 유럽 형질감염 시약 및 장비 시장의 성장을 위한 기회로 작용합니다.
유럽 형질감염 시약 및 장비 시장 개요
유럽 지역은 영국, 독일, 프랑스, 스페인, 이탈리아 및 기타 유럽 지역으로 분류됩니다. 영국은 2022년에 가장 큰 시장 점유율을 보유하고 있습니다. 제약 산업의 성장은 영국에서 진행 중인 고품질 연구 개발과 광범위하고 번성하는 의료 지식 기반에 의해 결정됩니다. 영국은 첨단 치료법의 연구, 개발, 제조, 임상 채택 및 상환을 위한 세계 최고의 생태계 중 하나입니다. 현재 영국에서는 85개 이상의 임상 시험이 진행 중이며 70개 CGT 회사가 잠재적인 치료 치료법을 개발하기 위해 노력하고 있습니다. Catapult는 영국의 CGT 생태계에 크게 기여해 온 최고의 회사입니다. 이는 국내 시약 및 장치 제조 공정 개발에 관여하는 상위 5개 회사 중 하나입니다. 이 회사는 최소한의 개입으로 변화하는 환경과 프로세스 요구 사항에 자동으로 적응할 수 있는 보다 스마트하고 자동화된 CGT 제조 프로세스를 개발하는 데 중점을 두고 있습니다. 따라서 생산성을 높이고 최종 제품 비용을 줄이기 위해 영국 기반 회사가 기울이는 노력은 영국의 세포 및 유전자 치료 시장의 성장을 이끄는 주요 요인입니다. 더욱이, 영국은 연구에 대한 지속적이고 목표화된 투자로 인해 유럽의 세포 및 유전자 치료 시장에서 강력한 위치를 차지하고 있으며, 이는 시장에 더욱 도움이 됩니다.
또한 프랑스에는 Sanofi SA, Ipsen, Pierre Fabre, HRA Pharma 및 TxCell(Sangamo Therapeutics, Inc.)과 같은 거대 바이오제약 및 제약회사가 있습니다. 이들 회사는 제품의 동결 건조가 필요한 백신 및 항체 개발에 참여하고 있으며 이는 형질감염 시약 및 장비에 대한 수요에 기여합니다.
2030년까지 유럽 형질감염 시약 및 장비 시장 수익 및 예측(미화 백만 달러)
유럽 형질감염 시약 및 장비 시장 세분화
유럽 형질감염 시약 및 장비 시장은 세분화되어 있습니다. 제품, 방법, 애플리케이션, 최종 사용자 및 국가를 기준으로 합니다.
제품을 기준으로 유럽 형질감염 시약 및 장비 시장은 시약 및 기기로 구분됩니다. 2022년에는 시약 부문이 더 큰 점유율을 차지했습니다.
방법 측면에서 유럽 형질감염 시약 및 장비 시장은 바이러스 방법, 비바이러스 방법, 하이브리드 방법으로 분류됩니다. 비바이러스 방법 부문은 2022년에 가장 큰 점유율을 차지했습니다. 바이러스 부문은 레트로바이러스, 아데노바이러스, 아데노 관련 바이러스 및 헤르페스 바이러스로 하위 분류됩니다. 비바이러스성 부분은 물리적/기계적 방법과 화학적 방법으로 구분됩니다. 또한 물리적/기계적 방법은 전기천공법, 미세주입법, 생물학적 방법, 레이저법, 자기감염법, 초음파천공법으로 분류됩니다. 또한 화학적 방법 부문은 리포솜 기반/고지질 기반과 비리포솜/고지질 기반으로 하위 분류됩니다.
응용 분야에 따라 유럽 형질감염 시약 및 장비 시장은 생물 의학 연구, 단백질 생산 및 치료 전달로 분류됩니다. 2022년에는 생물의학 연구 부문이 가장 큰 점유율을 차지했습니다.
최종 사용자를 기준으로 유럽 형질감염 시약 및 장비 시장은 학계 및 연구 기관과 제약 및 생명공학 회사로 구분됩니다. 2022년에는 학계 및 연구 기관 부문이 더 큰 점유율을 차지했습니다.
국가를 기준으로 유럽 형질감염 시약 및 장비 시장은 독일, 프랑스, 영국, 이탈리아, 스페인 및 기타 유럽 지역으로 분류됩니다. 영국은 2022년 유럽 형질감염 시약 및 장비 시장을 장악했습니다.
Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc 및 Polyplus-Transfection SA는 유럽 형질감염 시약 및 장비 시장에서 활동하는 선도적인 회사입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Europe Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Europe Market Analysis
5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis
6. Europe Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Transfection Reagents and Equipment Market -Country Analysis
10.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2 United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.3 Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.4 France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.5 Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.6 Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.7 Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Polyplus-Transfection SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. Europe Transfection Reagents and Equipment Market Segmentation
Table 2. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 45. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 46. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 47. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 48. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 49. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 50. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 51. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 52. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 53. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 54. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 55. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 56. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 57. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 58. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 59. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. Europe Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Europe Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Europe Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Europe: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.